Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

Evaluation of Protective Antibody Production After COVID-19 Vaccination Among Patients Under Hemodialysis

NCT04871945 is registered in ClinicalTrials.gov with Hanyang University Seoul Hospital as lead sponsor.

NCT NCT04871945
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT04871945 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
Evaluation of Protective Antibody Production After COVID-19 Vaccination Among Patients Under Hemodialysis
Lead sponsor
Hanyang University Seoul Hospital
Phase
Observational
Overall status
Completed
Start date
April 20, 2021
Completion date
October 31, 2021
Enrollment
31 (actual)
Sites
1

Conditions

As the registry lists them; a condition with its own page is linked.

covid19, end-stage renal disease, hemolysis, vaccine reaction